세계의 관절통 주사 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 주사 유형별, 용도별, 지역별, 경쟁별(2020-2030년)
Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection, By Application, By Region & Competition, 2020-2030F
상품코드:1728150
리서치사:TechSci Research
발행일:2025년 05월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 관절통 주사 시장 규모는 2024년에 46억 6,000만 달러로 평가되었고, 2030년에는 CAGR 7.02%로 강력한 성장이 전망됩니다.
이 시장 부문은 골관절염 및 류마티스 관절염과 같은 관절 관련 질환의 전 세계적인 발병률 증가에 부응합니다. 관절 통증 주사는 만성 관절 통증과 염증을 관리하기 위해 수술에 대한 최소 침습적이고 효과적인 대안을 제공합니다. 이러한 치료에는 코르티코스테로이드, 히알루론산, 다혈소판 혈장(PRP) 주사, 태반 조직 매트릭스 주사가 포함되며, 모두 통증을 줄이고 이동성을 개선하며 전반적인 관절 기능을 향상시키기 위해 고안되었습니다. 전 세계 인구의 고령화와 비수술적 치료 옵션에 대한 수요 증가로 시장 확대가 가속화되고 있습니다.
The Global Joint Pain Injections Market was valued at USD 4.66 billion in 2024 and is expected to witness robust growth, reaching significant market potential by 2030 with a CAGR of 7.02%. This market segment caters to the rising global incidence of joint-related disorders such as osteoarthritis and rheumatoid arthritis. Joint pain injections offer a minimally invasive and effective alternative to surgery for managing chronic joint pain and inflammation. These treatments include corticosteroids, hyaluronic acid, platelet-rich plasma (PRP), and placental tissue matrix injections, all designed to reduce pain, improve mobility, and enhance overall joint function. The aging global population and increasing demand for non-surgical treatment options are accelerating market expansion.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 4.66 Billion
Market Size 2030
USD 6.95 Billion
CAGR 2025-2030
7.02%
Fastest Growing Segment
Hyaluronic Acid Injections
Largest Market
North America
Key Market Drivers
Rising Obesity Rates
The growing prevalence of obesity is a key driver propelling the demand for joint pain injections worldwide. As obesity rates rise, so does the burden on weight-bearing joints, increasing the risk of joint disorders like osteoarthritis. According to the World Health Organization, the number of obese individuals has significantly increased over the past few decades, with over 650 million people classified as obese in 2016. Excess weight leads to greater stress on joints, resulting in chronic pain and inflammation that often necessitates medical intervention. Joint pain injections offer an effective solution for managing this discomfort and are increasingly sought after as part of long-term pain management strategies in obese populations.
Key Market Challenges
Reimbursement Issues
Reimbursement limitations pose a significant barrier to the widespread adoption of joint pain injections. In many healthcare systems, inadequate insurance coverage discourages patients from opting for injection-based therapies due to high out-of-pocket expenses. This is particularly true for newer or biologic-based treatments, which tend to be more expensive. As a result, despite clinical efficacy, limited reimbursement frameworks can hinder market growth by restricting patient access to advanced treatment options.
Key Market Trends
Advancements in Biologics and Regenerative Therapies
Technological progress in biologics and regenerative medicine is shaping a major trend in the joint pain injections market. Treatments such as platelet-rich plasma (PRP) and placental tissue matrix (PTM) injections are gaining attention for their ability to promote tissue repair and deliver extended relief from joint pain. These therapies utilize the patient's own biological components or donor-derived materials to regenerate damaged tissues, offering an innovative approach to joint restoration. Continued R&D in this area is expected to yield next-generation injectable solutions that offer superior outcomes and durability, further enhancing patient appeal and clinical adoption.
Key Market Players
Anika Therapeutics Inc
Bioventus LLC
Ferring Pharmaceuticals Inc
Sanofi SA
Pfizer Inc
Eli Lilly & Co
Flexion Therapeutics Inc
Teva Pharmaceutical Industries Ltd
Zimmer Biomet Holdings, Inc.
Report Scope:
In this report, the Global Joint Pain Injections Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Joint Pain Injections Market, By Type of Injection:
Steroid Joint Injections
Hyaluronic Acid Injections
Platelet-rich Plasma (PRP) Injections
Placental Tissue Matrix (PTM) Injections
Others
Joint Pain Injections Market, By Application:
Shoulder & Elbow
Knee & Ankle
Spinal Joints
Hip Joint
Others
Joint Pain Injections Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Joint Pain Injections Market.
Available Customizations:
Global Joint Pain Injections market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Joint Pain Injections Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
5.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
5.3.1. By Type of Injection
5.3.2. By Application
5.3.3. By Region
6. North America Joint Pain Injections Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
6.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Joint Pain Injections Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Injection
6.3.1.2.2. By Application
6.3.2. Canada Joint Pain Injections Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Injection
6.3.2.2.2. By Application
6.3.3. Mexico Joint Pain Injections Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Injection
6.3.3.2.2. By Application
7. Europe Joint Pain Injections Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
7.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Joint Pain Injections Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Injection
7.3.1.2.2. By Application
7.3.2. United Kingdom Joint Pain Injections Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Injection
7.3.2.2.2. By Application
7.3.3. France Joint Pain Injections Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Injection
7.3.3.2.2. By Application
7.3.4. Italy Joint Pain Injections Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Injection
7.3.4.2.2. By Application
7.3.5. Spain Joint Pain Injections Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Injection
7.3.5.2.2. By Application
8. Asia-Pacific Joint Pain Injections Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
8.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Joint Pain Injections Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Injection
8.3.1.2.2. By Application
8.3.2. Japan Joint Pain Injections Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Injection
8.3.2.2.2. By Application
8.3.3. India Joint Pain Injections Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Injection
8.3.3.2.2. By Application
8.3.4. Australia Joint Pain Injections Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Injection
8.3.4.2.2. By Application
8.3.5. South Korea Joint Pain Injections Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Injection
8.3.5.2.2. By Application
9. South America Joint Pain Injections Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
9.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Joint Pain Injections Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Injection
9.3.1.2.2. By Application
9.3.2. Argentina Joint Pain Injections Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Injection
9.3.2.2.2. By Application
9.3.3. Colombia Joint Pain Injections Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Injection
9.3.3.2.2. By Application
10. Middle East and Africa Joint Pain Injections Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others)
10.2.2. By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Joint Pain Injections Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Injection
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Joint Pain Injections Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Injection
10.3.2.2.2. By Application
10.3.3. UAE Joint Pain Injections Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Injection
10.3.3.2.2. By Application
10.3.4. Kuwait Joint Pain Injections Market Outlook
